Within the IPF cohort, they noted a trend toward the correlation between S100A9+CD163− monocyte percentages and serum surfactant protein-D (SP-D) levels, an established biomarker of alveolar damage [27]. Here, CD163 is linked to idiopathic pulmonary fibrosis.